US Edition
Emergent BioSolutions Inc. (EBS) Stock Analysis: Unlocking A Potential 93.13% Upside In The Healthcare Sector
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Emergent BioSolutions Inc. (EBS) Stock Analysis: Unlocking A Potential 93.13% Upside In The Healthcare Sector
Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector, is currently trading at $6.99 per share, showcasing a potential upside of 93.13% based on the average analyst target price of $13.50. With a market capitalization of $379.4 million, this U.S.-based life sciences company is known for its preparedness and response solutions to a variety of public health threats, including vaccines and treatments for anthrax, smallpox, a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
